Combination therapy: lonidamine, hyperthermia, and chemotherapy against the RIF-1 tumor in vivo.

Lonidamine enhances the cytotoxicity in vitro of several conventional antitumor drugs as well as that of hyperthermia (HT). We have investigated the possibility that such enhancement can also be demonstrated in vivo against the RIF-1 tumor system. Two assays were used to examine antitumor activity: tumor growth delay and clonogenicity of cells obtained from tumors from treated animals. We used drug (and HT) doses that by themselves did not achieve significant cell killing. The drugs whose interaction with lonidamine was tested were: cis-diamminedichloroplatinum (CDDP), mitomycin C (MMC), bleomycin, 5-fluorouracil, and nitrosourea. Of these only CDDP and MMC yielded positive data. Both assays gave essentially the same results, showing that antitumor activity reflected direct cell killing. CDDP and MCC activity was also enhanced by HT. When we combined all three modalities, however, the results of the trimodality therapies were no better than that of individual bimodality treatments. These last results suggest that lonidamine and HT have similar mechanisms, most likely inhibition of repair of DNA damage. Our data do suggest that lonidamine may have a role in multidrug therapies that include either CDDP or MMC as a component of the treatments.     

缺失型DMD／BMD患者PCR快速检测的可行性与意义

应用对应于Ｄｙｓｔｒｏｐｈｉｎ基因缺失热区的二对ＰＣＲ引物和一对内对照无关引物，在同一反应体系中扩增，检测６６例ＤＭＤ／ＢＭＤ患者。发现其中２５例存在１７号或４９号外显子缺失，与同时采用ｃＤＮＡ探针杂交检测出的３５例基因缺失相比．检出率达７１．４％。说明该扩增系统能够作为快速筛查缺失型ＤＭＤ／ＢＭＤ患者的有效手段。这对指导合理选用探针，尤其在产前诊断方面，具有重要意义。     

山东产四种菟丝子免疫增强作用的比较研究

目的 比较山东产四种菟丝子对小鼠免疫功能、抗疲劳、耐缺氧等方面的作用。方法 选用昆明种小鼠，用山东产四种菟丝子的水、醇提取物灌胃，观察小鼠腹腔巨噬细胞吞噬功能、免疫器官重量的变化、游泳实验和耐缺氧等指标。结果 山东产四种菟丝子均可增加小鼠吞噬百分率，使幼龄小鼠的胸腺和脾脏增重，并可显著延长小鼠的游泳及缺氧存活时间。其中以菟丝子和南方菟丝子的作用较好，水提取物的作用优于醇提取物。结论 山东产四种菟丝子具有增强机体免疫功能、抗疲劳、耐缺氧作用。菟丝子中的多糖是其提高机体免疫力，增强体质的有效物质之一。     

Clinical report of cervical arthroplasty in management of spondylotic myelopathy in Chinese

Objectives  

To investigate clinical effects and manual operational point of Bryan cervical disc prosthesis in Chinese, to observe the stability and range of movement (ROM) post-operatively.     

Breath-actuated inhalers in chronic asthma: comparison of Diskhaler and Turbohaler for delivery of beta-agonists.

An open, randomized, cross-over study was performed to compare the efficacy and acceptability of two breath-actuated inhalers, the Turbohaler (T) and Diskhaler (D), for delivery of beta-agonists. Thirty six adults with chronic asthma requiring beta-agonists four times daily were treated with terbutaline 500 micrograms via T and salbutamol 400 micrograms via D four times daily, each period lasting four weeks. Additional bronchodilator via pressurized aerosol was permitted as required. Peak expiratory flow (PEF) was recorded in the morning (before and after beta-agonist) and in the evening. The mean morning PEF was higher during the first two weeks using T (295 l.min-1) than whilst using D (281 l.min-1, p < 0.01), but this difference did not persist during the second two weeks and there were no differences in post-bronchodilator PEF or rescue beta-agonist use. After four weeks, > 90% of patients used both inhaler devices efficiently and they were equally acceptable in terms of ease of use and convenience to carry. The Diskhaler and Turbohaler achieve similar clinical efficacy for delivery of beta-agonists.     

人型支原体感染的血清流行病学研究

1989年3～4月对南京铁咯分局1423名健康人进行了人型支原体感染的血清流行病学调查。结果表明,人群中存在Mh感染抗体阳性率为3.72％,GMT为1:3.38。感染与性别、年龄、职业、婚姻、病史以及性接触等因素有关。提示该病是一种性传播疾病,应引起高度重视。     

维生素E对小鼠胸腺和脾脏T淋巴细胞转化及MΦ诱导IL－1的影响

ＶＥ缺乏组、１／３需要量组、需要量组、３倍需要量组、２０倍需要量组的初断奶小鼠喂养８周后观察Ｔ淋巴细胞转化及Ｍ中诱导ＩＬ－１反应。结果表明，ＶＥ增强半合适、合适剂量ＣｏｎＡ诱导的胸腺、脾脏Ｔ淋巴细胞转化，且半合适剂量诱导的反应高于合适剂量，ＶＥ增强合适剂量ＰＨＡ诱导的脾Ｔ细胞反应，但不影响其诱导胸腺Ｔ细胞反应。ＶＥ还提高ＭΦ诱导ＩＬ－１生成。上述实验以缺乏组反应最弱，３倍量组反应最强，而２０倍量组反有下降趋势。     

胸膜孤立性纤维瘤的CT表现

目的：分析胸膜孤立性纤维瘤的CT表现,以提高其认识和诊断水平。材料和方法：回顾性分析12例经病理证实的胸膜孤立性纤维瘤的CT表现。结果：12例中,CT平扫示肿瘤边界较光整,肿物中央可见低密度区9例。增强扫描肿物CT值增加15～46HU,均匀增强3例,不均匀增强9例,其间可见增强的血管。结论：胸膜孤立性纤维瘤的CT表现有一定特征性,典型病例可做术前诊断,CT后处理重建对病变的显示及诊断可提供很大的帮助。     

病案监控与医疗质量持续改进

医疗活动的每一个环节都在病案中有所反映。病案检查可以及时了解和掌握医疗中存在的问题。通过长期对病案环节质量和终末质量的同步检查、分析和评价，发现制度上的问题和漏洞，提示从质量环节上进行控制和改进，建立和完善医院医疗质量保障和持续改进体系，使医疗质量更优、更高。